Surveys conducted in differenc coutries and settings have described cancer breakthrough pain (CBTP) prevalence from 19 % to 98 %. Aim: To describe the CBTP in different clinical settings in Czech R epublic as for prevalence, clinical characteristics, treatment strategies used and patient satisfaction.